Early Market Access and Pricing with Pete Bak, Christian Thieniel and Brendan Wang
Early Market Access and Pricing with Pete Bak, Christian Thieniel and Brendan Wang
This is the first episode in our podcast series of Q&As on biopharma and medtech development—directly from active de... Read more
6 Jul 2022
•
29mins
Living Medicines – Current and Future Uses of Car T Cells with Peter Bak, PhD and Mike Bogetofte Barnkob, MD, PhD
Living Medicines – Current and Future Uses of Car T Cells with Peter Bak, PhD and Mike Bogetofte Barnkob, MD, PhD
In this episode of Back Bay’s industry podcast, The Life Science Report, Dr. Peter Bak is joined by Mike Bogetofte Barnk... Read more
19 May 2022
•
29mins
Similar Podcasts
BioCentury This Week
The Readout Loud
Talking Biotech with Dr. Kevin Folta
Freakonomics Radio
Planet Money
All-In with Chamath, Jason, Sacks & Friedberg
The Daily
Pivot
This American Life
The Bill Simmons Podcast
The Evolving Regulatory Framework for Novel Medicines in the EU
The Evolving Regulatory Framework for Novel Medicines in the EU
Biopharma companies looking to establish a footprint in Europe face country-specific decision-making processes. The heal... Read more
25 Apr 2022
•
25mins
The Commercial Potential of Optogenetic Therapies
The Commercial Potential of Optogenetic Therapies
Fifteen years ago, scientists discovered optogenetics, a technique of using light to stimulate light-sensitive receptors... Read more
15 Mar 2022
•
23mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
The Latest on Antibiotic Development, Back Bay Life Science Advisors with Antabio
The Latest on Antibiotic Development, Back Bay Life Science Advisors with Antabio
Antibiotics act as a safety net for all of healthcare. They make medical procedures such as surgeries, childbirth and ca... Read more
19 Jan 2022
•
22mins
Best Practices for Successful Sell-Side Licensing, Partnering and M&A
Best Practices for Successful Sell-Side Licensing, Partnering and M&A
Despite the heavy influx of capital over the past years, medtech or biopharma sell-side assignments can still be ripe wi... Read more
7 Jan 2022
•
25mins
Cell and Gene Therapy Investment Trends
Cell and Gene Therapy Investment Trends
Cell and gene therapies are currently among the hottest investments in the biotech space, both in the public and private... Read more
22 Nov 2021
•
19mins
MedTech Investing with Paul LaViolette of SV Health Investors and Jonathan P. Gertler, MD, Back Bay Life Science Advisors and BioVentures Medtech Funds
MedTech Investing with Paul LaViolette of SV Health Investors and Jonathan P. Gertler, MD, Back Bay Life Science Advisors and BioVentures Medtech Funds
“I have a deep belief that medtech and healthtech are going to carry us forward to markedly improve delivery and quality... Read more
13 Oct 2021
•
26mins
Remote Patient Monitoring
Remote Patient Monitoring
One of the unexpected outcomes of the COVID-19 pandemic has been the rapid and widespread uptake of remote patient monit... Read more
5 Aug 2021
•
26mins
New Drug Pricing and Market Access
New Drug Pricing and Market Access
In this episode of our life science industry podcast, Dr. Peter Bak sits down with Brendan Wang and Christian Thienel of... Read more
30 Jun 2021
•
26mins
